Brain atrophy and demyelination in MOGAD, AQP4+NMOSD and seronegative NMOSD

被引：0
|
作者：
Hagbohm, Caroline [1 ,2 ]
Ouellette, Russell [1 ,2 ]
Jonsson, Dagur Ingi [2 ,3 ]
Iacobaeus, Ellen [2 ,4 ]
Granberg, Tobias [1 ,2 ]
机构：
[1] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Neurophysiol, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1447/2506
引用
收藏
页码：920 / 920
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of Inebilizumab in AQP4+NMOSD participants with history of immunosuppression treatment prior to N-MOmentum study
    Paul, F.
    Marignier, R.
    Lindsey, J. W.
    Kim, H. J.
    She, D.
    Cimbora, D.
    Patterson, K. R.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 422 - 423
  • [32] Biopsy Proven Aqp4-Ig G Seronegative Nmosd Case: Benign Course with No Treatment
    Altintas, A.
    Akinci, Y.
    Kaya, Z. E.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 420 - 420
  • [33] Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD
    Lin, Liuyu
    Wu, Yuqing
    Hang, Hailun
    Lu, Jie
    Ding, Yuanliang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] A challenging case of a AQP-4-seronegative, anti-MOG positive, NMOSD patient.
    Karageorgiou, Clementine
    Giannouli, Ermioni
    NEUROLOGY, 2017, 88
  • [35] Safety and Efficacy of Inebilizumab in AQP4+NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study
    Paul, Friedemann
    Marignier, Roman
    Lindsey, John
    Kim, Ho Jin
    She, Dewei
    Cimbora, Daniel
    Patterson, Kristina
    Cree, Bruce
    NEUROLOGY, 2023, 100 (17)
  • [36] Safety and Efficacy of Inebilizumab in AQP4+NMOSD Participants with history of Immunosuppression Treatment prior to N-MOmentum Study
    Kim, Ho Jin
    Patterson, Kristina
    Paul, Friedemann
    Marignier, Romain
    Lindsey, J. W.
    She, Dewei
    Dinh, Quinn
    Cimbora, Dan
    Cree, Bruce A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (07) : NP8 - NP9
  • [37] Neuromyelitis Optica Spectrum Disorders (NMOSD) and AQP4-IgG in an Australian Pediatric Demyelination Cohort
    Dahan, Ariel
    Dale, Russell
    Brilot, Fabienne
    Kornberg, Andrew
    Yiu, Eppie
    NEUROLOGY, 2016, 86
  • [38] Neuromyelitis Optica Spectrum Disorders (NMOSD) and AQP4-IgG in an Australian Pediatric Demyelination Cohort
    Dahan, Ariel
    Dale, Russell
    Brilot, Fabienne
    Kornberg, Andrew
    Yiu, Eppie
    NEUROLOGY, 2016, 86
  • [39] Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD
    Kaneko, Kimihiko
    Kuroda, Hiroshi
    Matsumoto, Yuki
    Sakamoto, Naohiro
    Yamazaki, Naoya
    Yamamoto, Naoki
    Umezawa, Shu
    Namatame, Chihiro
    Ono, Hirohiko
    Takai, Yoshiki
    Takahashi, Toshiyuki
    Fujimori, Juichi
    Nakashima, Ichiro
    Harigaya, Yasuo
    Lassmann, Hans
    Fujihara, Kazuo
    Misu, Tatsuro
    Aoki, Masashi
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (05):
  • [40] Severe Myelitis After a Long Interval of 20 Years From anEarlier Optic Neuritis Episode in Undiagnosed AQP4+NMOSD
    Tan, HuiJieh
    VernEw, Ju
    Wong, Daniel Yi Jie
    Eow, Gaik Bee
    Hor, JyhYung
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP94 - NP94
12345